Nancy A Rigotti1,2,3,4, Yuchiao Chang5,6, Lisa C Rosenfeld7,8, Sandra J Japuntich9,10, Elyse R Park11,12,7,8, Hilary A Tindle13, Douglas E Levy11,12,6, Zachary Z Reid11, Joanna Streck14, Timothy Gomperts11, Jennifer H K Kelley11,12, Daniel E Singer5,6,15. 1. Tobacco Research and Treatment Center, Massachusetts General Hospital, 50 Staniford St., Room #914, Boston, MA, 02114, USA. nrigotti@partners.org. 2. Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, 50 Staniford St., Room #914, Boston, MA, 02114, USA. nrigotti@partners.org. 3. Mongan Institute for Health Policy, Massachusetts General Hospital, Boston, MA, USA. nrigotti@partners.org. 4. Department of Medicine, Harvard Medical School, Boston, MA, USA. nrigotti@partners.org. 5. Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, 50 Staniford St., Room #914, Boston, MA, 02114, USA. 6. Department of Medicine, Harvard Medical School, Boston, MA, USA. 7. Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA. 8. McLean Hospital, Providence, RI, USA. 9. Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, RI, USA. 10. Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA. 11. Tobacco Research and Treatment Center, Massachusetts General Hospital, 50 Staniford St., Room #914, Boston, MA, 02114, USA. 12. Mongan Institute for Health Policy, Massachusetts General Hospital, Boston, MA, USA. 13. Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA. 14. Department of Psychological Science, University of Vermont, Burlington, VT, USA. 15. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Abstract
BACKGROUND: Hospitalization offers smokers an opportunity to quit smoking. Starting cessation treatment in hospital is effective, but sustaining treatment after discharge is a challenge. Automated telephone calls with interactive voice response (IVR) technology could support treatment continuance after discharge. OBJECTIVE: To assess smokers' use of and satisfaction with an IVR-facilitated intervention and to test the relationship between intervention dose and smoking cessation. DESIGN: Analysis of pooled quantitative and qualitative data from the intervention groups of two similar randomized controlled trials with 6-month follow-up. PARTICIPANTS: A total of 878 smokers admitted to three hospitals. All received cessation counseling in hospital and planned to stop smoking after discharge. INTERVENTION: After discharge, participants received free cessation medication and five automated IVR calls over 3 months. Calls delivered messages promoting smoking cessation and medication adherence, offered medication refills, and triaged smokers to additional telephone counseling. MAIN MEASURES: Number of IVR calls answered, patient satisfaction, biochemically validated tobacco abstinence 6 months after discharge. KEY RESULTS: Participants answered a median of three of five IVR calls; 70% rated the calls as helpful, citing the social support, access to counseling and medication, and reminders to quit as positive factors. Older smokers (OR 1.36, 95% CI 1.20-1.54 per decade) and smokers hospitalized for a smoking-related disease (OR 1.65, 95% CI 1.21-2.23) completed more calls. Smokers who completed more calls had higher quit rates at 6-month follow-up (OR 1.49, 95% CI 1.30-1.70, for each additional call) after multivariable adjustment for age, sex, education, discharge diagnosis, nicotine dependence, duration of medication use, and perceived importance of and confidence in quitting. CONCLUSIONS: Automated IVR calls to support smoking cessation after hospital discharge were viewed favorably by patients. Higher IVR utilization was associated with higher odds of tobacco abstinence at 6-month follow-up. IVR technology offers health care systems a potentially scalable means of sustaining tobacco cessation interventions after hospital discharge. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov Identifiers NCT01177176, NCT01714323.
RCT Entities:
BACKGROUND: Hospitalization offers smokers an opportunity to quit smoking. Starting cessation treatment in hospital is effective, but sustaining treatment after discharge is a challenge. Automated telephone calls with interactive voice response (IVR) technology could support treatment continuance after discharge. OBJECTIVE: To assess smokers' use of and satisfaction with an IVR-facilitated intervention and to test the relationship between intervention dose and smoking cessation. DESIGN: Analysis of pooled quantitative and qualitative data from the intervention groups of two similar randomized controlled trials with 6-month follow-up. PARTICIPANTS: A total of 878 smokers admitted to three hospitals. All received cessation counseling in hospital and planned to stop smoking after discharge. INTERVENTION: After discharge, participants received free cessation medication and five automated IVR calls over 3 months. Calls delivered messages promoting smoking cessation and medication adherence, offered medication refills, and triaged smokers to additional telephone counseling. MAIN MEASURES: Number of IVR calls answered, patient satisfaction, biochemically validated tobacco abstinence 6 months after discharge. KEY RESULTS:Participants answered a median of three of five IVR calls; 70% rated the calls as helpful, citing the social support, access to counseling and medication, and reminders to quit as positive factors. Older smokers (OR 1.36, 95% CI 1.20-1.54 per decade) and smokers hospitalized for a smoking-related disease (OR 1.65, 95% CI 1.21-2.23) completed more calls. Smokers who completed more calls had higher quit rates at 6-month follow-up (OR 1.49, 95% CI 1.30-1.70, for each additional call) after multivariable adjustment for age, sex, education, discharge diagnosis, nicotine dependence, duration of medication use, and perceived importance of and confidence in quitting. CONCLUSIONS: Automated IVR calls to support smoking cessation after hospital discharge were viewed favorably by patients. Higher IVR utilization was associated with higher odds of tobacco abstinence at 6-month follow-up. IVR technology offers health care systems a potentially scalable means of sustaining tobacco cessation interventions after hospital discharge. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov Identifiers NCT01177176, NCT01714323.
Authors: Robert D Reid; Kerri-Anne Mullen; Monika E Slovinec D'Angelo; Debbie A Aitken; Sophia Papadakis; Patricia M Haley; Christine A McLaughlin; Andrew L Pipe Journal: Nicotine Tob Res Date: 2009-11-10 Impact factor: 4.244
Authors: Sharon E Cummins; Anthony C Gamst; Kendra Brandstein; Gregory B Seymann; Hillary Klonoff-Cohen; Carrie A Kirby; Elisa K Tong; Edward Chaplin; Gary J Tedeschi; Shu-Hong Zhu Journal: Am J Prev Med Date: 2016-10 Impact factor: 5.043
Authors: Nancy A Rigotti; Susan Regan; Douglas E Levy; Sandra Japuntich; Yuchiao Chang; Elyse R Park; Joseph C Viana; Jennifer H K Kelley; Michele Reyen; Daniel E Singer Journal: JAMA Date: 2014-08-20 Impact factor: 56.272
Authors: John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan Journal: Nicotine Tob Res Date: 2003-02 Impact factor: 4.244
Authors: Martin C Mahoney; Deborah O Erwin; Annamaria Masucci Twarozek; Frances G Saad-Harfouche; Elisa M Rodriguez; Xiaoxi Sun; Willie Underwood; Chester Fox Journal: Prev Med Date: 2018-06-25 Impact factor: 4.018
Authors: Eve Angeline Hood-Medland; Susan L Stewart; Hien Nguyen; Mark Avdalovic; Scott MacDonald; Shu-Hong Zhu; Antonio Mayoral; Elisa K Tong Journal: Appl Clin Inform Date: 2019-10-02 Impact factor: 2.342
Authors: Titus Josef Brinker; Christian Martin Brieske; Stefan Esser; Joachim Klode; Ute Mons; Anil Batra; Tobias Rüther; Werner Seeger; Alexander H Enk; Christof von Kalle; Carola Berking; Markus V Heppt; Martina V Gatzka; Breno Bernardes-Souza; Richard F Schlenk; Dirk Schadendorf Journal: J Med Internet Res Date: 2018-08-15 Impact factor: 5.428
Authors: James M Davis; Leah C Thomas; Jillian E H Dirkes; H Scott Swartzwelder Journal: Int J Environ Res Public Health Date: 2020-08-21 Impact factor: 3.390
Authors: Heather D'Angelo; Sarah D Hohl; Betsy Rolland; Robert T Adsit; Danielle Pauk; Michael C Fiore; Timothy B Baker Journal: Transl Behav Med Date: 2022-05-26 Impact factor: 3.626
Authors: Lisa M Quintiliani; Hasmeena Kathuria; Ve Truong; Jennifer Murillo; Belinda Borrelli; Ziming Xuan; Karen E Lasser Journal: Addict Behav Date: 2020-09-15 Impact factor: 3.913